Live Breaking News & Updates on Joint Research Supervisor

MELBOURNE, Australia (BUSINESS WIRE) Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced today that the Company appointed Ms. Belen Toledo MSc., a biotechnologist specializing in cell regenerative medicine, to evaluate the ....

Juan Antonio Marchal , Juan Marchal , Belen Toledo , Aitor Gonz , Belen Toledo Msc , Julian Kenyon , Research Supervisor , Drug Discovery Program , University Of Granada , Company Registration Statement On Form , Centre For Biomedical Research , Company Mechanism Of Action , Exchange Commission , Propanc Biopharma Inc , Granada University , Propanc Biopharma , Proenzymes Optimization Project , Joint Research , Biomedical Research , Macarena Per , Joint Research Supervisor , Chief Scientific Officer , Registration Statement , ஜுவான் அன்டோனியோ மார்ச்சல் , ஜுவான் மார்ச்சல் , பேலென் டோலிடோ ,